The potential of oral fluid in drug monitoring: an update

References

• 1. Desrosiers NA, Huestis MA. Oral fluid drug testing: analytical approaches, issues and interpretation of results. J. Anal. Toxicol. 43(6), 415–443 (2019).
  Medline CASGoogle Scholar
• 2. Gröschl M. Saliva: a reliable sample matrix in bioanalytics. Bioanalysis 9(8), 655–668 (2017).
  Google Scholar
• 3. Elmongy H, Abdel-Rehim M. Saliva as an alternative specimen to plasma for drug bioanalysis: a review. TrAC Trends Anal. Chem. 83, 70–79 (2016).
  CASGoogle Scholar
• 4. D'Orazio AL, Mohr ALA, Chan-Hosokawa A et al. Recommendations for toxicological investigation of drug-impaired driving and motor vehicle fatalities-2021 update. J. Anal. Toxicol. 45(6), 529–536 (2021).
  MedlineGoogle Scholar
• 5. Neumann J, Beck O, Dahmen N, Böttcher M. Potential of oral fluid as a clinical specimen for compliance monitoring of psychopharmacotherapy. Ther. Drug Monit. 40(2), 245–251 (2018).
  Medline CASGoogle Scholar
• 6. Han Y, Li X-L, Zhang M, Wang J, Zeng S, Min JZ. Potential use of a dried saliva spot (DSS) in therapeutic drug monitoring and disease diagnosis. J. Pharm. Anal. 12(6), 815–823 (2022).
  MedlineGoogle Scholar
• 7. Soares S, Rosado T, Barroso M, Gallardo E. New method for the monitoring of antidepressants in oral fluid using dried spot sampling. Pharmaceuticals 14(12), 1–20 (2021).
  Google Scholar
• 8. Carvalho J, Rosado T, Barroso M, Gallardo E. Determination of antiepileptic drugs using dried saliva spots. J. Anal. Toxicol. 43(1), 61–71 (2019).
  Medline CASGoogle Scholar
• 9. Mashal MS, Bevalot F, Citterio-Quentin A et al. Comparative study between direct analysis in whole blood, oral fluid, and declaration of consumption for the prevalence of nonsteroidal anti-inflammatory drugs and acetaminophen in ultratrail runners. Drug Test. Anal. 15(1), 97–103 (2023).
  Medline CASGoogle Scholar
• 10. Lierheimer S, Beck O, Keller T, Monticelli FC, Böttcher M. Hydromorphone and codeine concentrations in oral fluid specimens from patients receiving substitution therapy with Substitol™ (morphine sulfate). Drug Test. Anal. 13(10), 1743–1748 (2021).
  Medline CASGoogle Scholar
• 11. Shaparin N, Mehta N, Kunkel F, Stripp R, Borg D, Kolb E. A novel chronic opioid monitoring tool to assess prescription drug steady state levels in oral fluid. Pain Med. 18(11), 2162–2169 (2017).
  MedlineGoogle Scholar
• 12. Granzotto FCN, da Silva ACC, Lizot LF, Antunes MV, Linden R. Dried plasma spots and oral fluid as alternative matrices for therapeutic drug monitoring of busulfan: analytical method development and clinical evaluation. Ther. Drug Monit. 43(3), 376–385 (2021).
  Medline CASGoogle Scholar
• 13. Richter LHJ, Jacobs CM, Mahfoud F, Kindermann I, Böhm M, Meyer MR. Development and application of a LC-HRMS/MS method for analyzing antihypertensive drugs in oral fluid for monitoring drug adherence. Anal. Chim. Acta 1070, 69–79 (2019).
  Medline CASGoogle Scholar
• 14. Almukainzi M. Saliva sampling in therapeutic drug monitoring and physiologically based pharmacokinetic modeling: review. Drug Res. (Stuttg.) 73(2), 65–69 (2023).
  Medline CASGoogle Scholar
• 15. Comiran E, Carlos G, Barreto F, Pechanksy F, Fröehlich PE, Limberger RP. Lisdexamfetamine and amphetamine pharmacokinetics in oral fluid, plasma, and urine after controlled oral administration of lisdexamfetamine. Biopharm. Drug Dispos. 42(1), 3–11 (2021).
  Medline CASGoogle Scholar
• 16. Smith CR, Swortwood MJ. Analysis of methylphenidate, ethylphenidate, lisdexamfetamine, and amphetamine in oral fluid by liquid chromatography-tandem mass spectrometry. J. Forensic Sci. 67(2), 669–675 (2022).
  Medline CASGoogle Scholar
• 17. Blandino V, Wetzel J, Kim J, Haxhi P, Curtis R, Concheiro M. Oral fluid vs. urine analysis to monitor synthetic cannabinoids and classic drugs recent exposure. Curr. Pharm. Biotechnol. 18(10), 796–805 (2017).
  Medline CASGoogle Scholar
• 18. Palmquist KB, Swortwood MJ. Data-independent screening method for 14 fentanyl analogs in whole blood and oral fluid using LC-QTOF-MS. Forensic Sci. Int. 297, 189–197 (2019).
  Medline CASGoogle Scholar
• 19. Polet M, De Wilde L, Van Renterghem P, Van Gansbeke W, Van Eenoo P. Potential of saliva steroid profiling for the detection of endogenous steroid abuse: reference thresholds for oral fluid steroid concentrations and ratios. Anal. Chim. Acta 999, 1–12 (2018).
  Medline CASGoogle Scholar